Archives for October 28, 2004

← 2004

People on the move

Bristol-Myers Squibb has announced the sudden death of James Palmer, aged 51, the firm's chief scientific officer and president of the Pharmaceutical Research Institute. His death occurred after undergoing surgery. Elliot Sigal, BMS' senior vice...

Roche partners next-gen hep C therapy

Pharmasset of the US could receive funding of $168 million (€131.8m) in upfront and milestone payments - with the prospect of receiving more - after licensing its preclinical hepatitis C drug programme to Swiss drug giant Roche.

Invitrogen buys nucleic acid purification firm

Invitrogen, which supplies reagents, services and software for the life science market, has continued its acquisitive streak with the announcement that it is paying $35 million (€27.5m) for a UK firm - DNA Research Innovations - specialising in...

Bruker launches next-gen MALDI-TOF/TOF system

Bruker Daltonics, has launched a new MALDI-TOF and TOF mass spectrometer that offers improved sensitivity, resolution and mass accuracy of TOF/TOF systems for expression proteomics, quantitative proteomics and biomarker discovery.

Qiagen launches EU-approved NA purification system

Qiagen has launched the world's first automated sample preparation system for viral nucleic acids to aid molecular diagnostics that conforms to a European Union Directive on in vitro diagnostic medical devices.

Accelrys reports disappointing 2Q performance

Accelrys has reported a decrease in revenue in the second quarter of the year. Revenues were slightly down but the company saw a substantial increase in net loss for this year, which it attributed to 'change in revenue recognition.'